Taro Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
TARO has two hundred and fifty-three approved drugs.
There are eight US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.
There are thirty-one patent family members on TARO drugs in twelve countries and one hundred and seventy-three supplementary protection certificates in fourteen countries.
Summary for Taro
International Patents: | 31 |
US Patents: | 8 |
Tradenames: | 133 |
Ingredients: | 116 |
NDAs: | 253 |
Patent Litigation for Taro: | See patent lawsuits for Taro |
PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | CREAM, AUGMENTED;TOPICAL | 076543-001 | Dec 9, 2003 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Taro | AMMONIUM LACTATE | ammonium lactate | CREAM;TOPICAL | 075883-001 | Apr 10, 2003 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Taro | MICONAZOLE NITRATE | miconazole nitrate | CREAM;VAGINAL | 074444-001 | Jan 13, 1997 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Taro | MINOXIDIL (FOR MEN) | minoxidil | AEROSOL, FOAM;TOPICAL | 209074-001 | Dec 31, 2018 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Taro | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | cetirizine hydrochloride | SOLUTION;ORAL | 090182-001 | Apr 22, 2008 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 5,881,926 | ⤷ Try a Trial |
Taro | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,399,079 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,071,523 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 5,881,926 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112012017554 | ⤷ Try a Trial |
Japan | 2009500422 | ⤷ Try a Trial |
European Patent Office | 1898707 | ⤷ Try a Trial |
Canada | 2822220 | ⤷ Try a Trial |
Israel | 187666 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1305329 | 08C0014 | France | ⤷ Try a Trial | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
0806968 | SPC/GB07/011 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003 |
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1713823 | 1490064-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
1874117 | 2014/032 | Ireland | ⤷ Try a Trial | PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.